Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Schedule of Segment Profitability That Are Most Relied Upon By the Codm Are Gross Revenues and Net Loss

The measures of segment profitability that are most relied upon by the CODM are gross revenues and net loss, as presented within the table below and reconciled to the statement of operations.

	Year Ended December 31, 2023
	Dominari Financial			Legacy AIkido Pharma			Consolidated
Revenue		2,039			-			2,039
Operating Costs
General and administrative		15,750			8,088			23,839
Research and development		-			(3	)		(3	)
Loss from operations		(13,711	)		(8,085	)		(21,797	)
Other (expenses) income
Other income		-			36			36
Interest income		229			487			716
Gain on marketable securities		-			630			630
Unrealized loss on note receivable		-			(3,248	)		(3,248	)
Change in fair value of investments		-			780			780
Total other (expenses) income		229			(1,315	)		(1,086	)
Net loss		(13,482	)		(9,400	)		(22,882	)

	Year Ended December 31, 2022
	Dominari Financial			Legacy AIkido Pharma			Consolidated
Revenue	-			-			-
Operating Costs
General and administrative		157			11,526			11,683
Research and development		-			2,663			2,663
Loss from operations		(157	)		(14,189	)		(14,346	)
Other (expenses) income
Other income		-			64			64
Interest income		-			687			687
Gain on marketable securities		-			(5,952	)		(5,952	)
Unrealized loss on note receivable		-			-			-
Change in fair value of investments		-			(2,560	)		(2,560	)
Total other (expenses) income		-			(7,761	)		(7,761	)
Net loss		(157	)		(21,950	)		(22,107	)